Cardiovascular and Heart Health Benefits Beyond Weight Loss The LEADER, SUSTAIN-6, and SELECT trials documented that GLP-1 medications reduce major adverse cardiovascular events (heart attack, stroke, cardiovascular death) by 2635% in patients with existing heart disease or high cardiovascular risk
GLP-1 medicines are used for some tamariki and rangatahi with diabetes
Understanding GLP-1 Role in Weight Management GLP-1 stands as a leader in the field of weight management, specifically targeting brain regions responsible for controlling appetite
This peptide can help support tissue healing , particularly in tendons, ligaments, skeletal muscle, and bone, as well as angiogenesis, or the production of new blood vessels from existing ones
Phase 3 trials are still running, and Eli Lilly is expected to submit retatrutide for regulatory approval once the remaining trials report results across 2026